Summary.-In a retrospective study we have used an immunoperoxidase procedure to localize the glycoprotein fibronectin in human rectal carcinomas, concentrating on tumour invading thick-walled extramural veins. Fibronectin was present in 29 out of 38 cases, in connective tissue stroma, and was not in direct association with the tumour cells, except in areas of necrosis. We found no correlation between the presence or absence of stromal fibronectin and (1) the degree of cellular differentiation within the tumour, (2) tumour progression (Dukes' classification) (3) the subsequent development of metastases and (4) patient longevity. Our results do not support the conclusions from in vitro studies (Smith et al., 1979) that the metastatic potential of carcinomas may be partly determined by the ability of tumour cells to synthesize pericellular fibronectin.
CURRENT INTEREST in the high-mol.-wt glycoprotein fibronectin stems from the observation that, whilst it is associated with the surface of a variety of normal cell lines in culture, particularly those of mesenchymal origin, it is largely absent from their tumour-virus-transformed derivatives (Hynes et al., 1978; Yamada & Olden, 1978) . The relationship between loss of surface fibronectin and other characteristics of the transformed phenotype (e.g. rounded morphology, loss of contact inhibition) is now clear, and relates to the role of fibronectin as a matrix component important for cell adhesion (Ruoslahti et al., 1981; Kleinman et al., 1981) . However, the correlation, if any, between loss of fibronectin in vitro and increased tumorigenic potential of transformed cells in vivo has been the subject of conflicting reports (Chen et al., 1976; Gallimore et al., 1979; Der & Stanbridge 1978 Kahn & Shin 1979) . In a recent study , Smith et al. (1979) found that human epithelial cell lines derived from primary carcinomas or non-malignant tissues showed extensive deposition of matrix fibronectin, whereas lines from metastatic carcinomas expressed little such material. One interpretation of these findings is that a better correlation exists between loss of fibronectin and increased metastatic potential than with tumorigenicity per se. However, the need to examine human tumour material directly and avoid possible artifacts generated by taking cells into culture is obvious.
In a previous study of carcinoma of rectum, Talbot et al. (1980) showed that primary adenocarcinoma was invading rectal veins in 520% of 703 cases. The prognosis was found to depend on the extent of venous invasion, and was particularly poor when there was spread of tumour into large (thick-walled) extramural veins (Talbot et al., 1981 Whether this is because of variation in the intrinsic nature of the invading adenocarcinoma or due to variation in reactivity of the host tissues at the primary or potential secondary sites is unclear. One possibility is that the adhesiveness and cohesion of the adenocarcinoma cells within invaded veins is greater in some tumours than in others. Because of the suggestions from in vitro evidence that cell adhesion is mediated by fibronectin we decided to examine tissue from the cases of rectal adenocarcinoma previously investigated by Talbot et al. (1980 Talbot et al. ( , 1981 to determine whether any correlation exists between the absence of fibronectin from tumour within extramural veins, metastatic spread and patient longevity.
MATERIALS AND METHODS
Tissue sections8.-Five-/utm paraffin sections were cut from blocks of the same cases of surgically excised rectal adenocarcinoma that w%Nere previously investigated by Talbot et al. (1980 Talbot et al. ( , 1981 . Only those blocks which included invasion of thick-walled extramural veins by the tumour were studied. (The material is held at the Department of Pathology, St Mark's Hospital, London.)
Anti-serum to human plasma fibronectin.-Fibronectin w%as purified from outdated citrated human plasma by gelatin-Sepharose chromatography (Engvall & Ruoslahti, 1977) followed by preparative SDS-polyacrylamidegel electrophoresis. The protein recovered by electroelution gave a single band on 700 SDS-polyacrylamide gels. Rabbits were injected s.c. with 1 mg of fibronectin in complete Freund's adjuvant, followed by 2 booster injections (0.5 mg each) at 2-week intervals. The animals were bled 10 days later, and the antiserum characterized by immunodiffusion and immunoelectrophoresis. Whilst the antiserum cross-reacted with both urea-eluted and arginine-eluted fibronectin. as well as with human plasma, it did not cross-react with human serum albumin. fibrinogen, fibronectin-depleted plasma or gelatin. Anti-fibronectin antibodies were subsequently purified by affinity chromatography on a fibronectin-Sepharose column, as described by Yamada (1978) .
Immunohistochemical localization of fibronectin. Sections of biopsy material were stained for fibronectin using a 3-layeredbridge technique with a peroxidase antiperoxidase (PAP) complex (Sternberger et al., 1970) . Some of the improvements suggested by Strauss (1979) were used, including the use of phenylhydrazine to block endogenous peroxidase activity, and 01M imidazole buffer (pH 7.0) to improve the staining with 3,4,3'4', tetra-aminobiphenyl hydrochloride.
In addition, normal serum from the species supplying the secondary antibody (swine) was used to block nonspecific tissue-binding sites as suggested by De Lellis et al. (1979) . The swine serum was first depleted of fibronectin by passage through two gelatinSepharose columns. As the tissues had been fixed in formalin, all sections were treated with trypsin to unmask potential antigenic sites (Brozman, 1978) , though pilot experiments showed that this step did not affect the intensity of the staining for fibronectin. Staining was optimal with an anti-fibronectin concentration of 50 Hug/ml, and was quantitatively removed by adsorbing the antibody with fibronectin. There was no staining in the presence of non-immune immunoglobulins (50 ,ug/ml). The final staining protocol adopted is given in Table I .
Sections from each case were stained both with anti-fibronectin and non-immune immunoglobulins to determine the presence or absence of fibronectin from tumour within thick-walled extramural veins.
RESULTS
Staining of tumour in thick-walled extramural veins for fibronectin showed the following characteristics. Clearly viable tumour cells were generally substantially unstained for fibronectin, though occasional cells showed definite positive staining. There was no evidence that tumour cells were associated with a pericellular matrix of fibronectin (Fig. 1) . In contrast, necrotic cells, when present, gave strong positive staining for fibronectin, whilst the corresponding control sections were uniformly negative. The bulk of the fibronectin was generally associated with the connective tissue stroma, which was always present (Fig. 1) , though the amount in the individual cases was variable.
The relationship between stromal staining for fibronectin and the histological grade (degree of differentiation) of the tumours is shown in Table II Out of 38 cases of thick-walled venous invasion, 29 showed tumours which were positive for stromal fibronectin, yet 22 of these developed metastases (Table IV) . Of the 9 cases in which the tumour contained no stromal fibronectin, only 4 developed metastases. Analysis of the data by log-rank correlation clearly showed that the absence of stromal fibronectin is not significantly related to metastatic spread (P < 0 1), nor to patient survival (P<0 1), (Fig. 2) .
DISCUSSION
The distribution of fibronectin in normal human rectal mucosa has recently been examined by Scott et at. (1981) using immunofluorescence and immuno-peroxidase techniques. The most prominent staining for fibronectin was found in the connective tissue of the lamina propria, though fibronectin was also found in and around some apical epithelial cells and in the underlying basement membranes. In an earlier study, fibronectin was also found associated with the basement membrane under crypt cells in rat small intestine (Quaroni et al., 1978) . The distribution is consistent with the idea that fibronectin is important in adhesion of cells (including epithelial cells) to basement membranes. In the present study of 40 cases, we (Sternberger, 1979) Vaheri ( 1981) , who found that, although sarcomas produce fibronectin in vivo, carcinoma cells do not. The deposition of a fibronectin-containing pericellular matrix would therefore appear to be associated with tumour cells of mesenchymal rather than epithelial origin. The strong positive staining for fibronectin in necrotic cells is difficult to explain, but would not appear to be a method artifact. One possible explanation is that the fibronectin originates from the plasma as a host measure to opsonize necrotic cells before phagocytosis by macrophages (Saba et al., 1980) . However, as necrosis is presumed to be due to ischaemia it is difficult to see how plasma fibronectin could reach such a location. Whilst fibronectin was not generally associated directly with the tumour cells, it was found in the connective-tissue stroma of most of our cases (29/38). This result agrees with that of Stenman & Vaheri (1981) , who found fibronectin in the stroma of a variety of carcinomas, including adenocarcinoma of the colon. Although fibroblasts are likely to be the source of this fibronectin, the possibility that other cell types, including epithelial cells, contribute this material cannot be excluded. More detailed information on the ability of the various cell types within the tumour to synthesize fibronectin may come from immuno-electron microscopy. Our results clearly establish that there is no correlation between this stromal fibronectin and the level of differentiation of cells within the tumour, though fibronectin has been shown to influence morphology in vitro (Hynes et al., 1978; Yamada & Olden, 1978) as well as certain aspects of cellular differentiation (West et al., 1979; Podleski et al.. 1979) . Tumour progression, metastasis and patient longevity also failed to correlate with the presence of stromal fibronectin. Although loss of adhesiveness has long been thought important in the invasion and dissemination of malignant tumours (Abercrombie & Ambrose, 1962) , the idea that fibronectin within carcinomatous tissue might limit tumour metastasis through its ability to promote cell adhesion would appear to be incorrect. Indeed, Vlodavsky & Gospodarowicz (1981) have recently shown that a coloniccarcinoma cell line was unable to adhere to culture dishes coated with fibronectin, although they were able to attach and spread on the glycoprotein laminin. The role of laminin as an adhesive glycoprotein specific for cells of epithelial origin has been confirmed in other systems (Terranova et al., 1980; Kleinman et al., 1981) . These results indicate a need to re-examine our cases to search for a correlation between the levels of laminin, metastasis and patient longevity.
